“These findings suggest that when a CVC is inserted in patients requiring anticoagulant therapy, the possible risk of excessive bleeding must be carefully considered” Hwang et al (2014).
Reference:
Hwang, B.Y., Kim, E., Kim, W.S., Cho, A.R., Cho, M.J. and Lee, C.W. (2014) Hemorrhagic shock occurring due to a concealed hematoma after insertion of a subclavian venous catheter in a patient undergoing anticoagulation therapy: a case report. Korean Journal of Anesthesiology. 67(5), p.358-362.
[ctt tweet=”Concealed hematoma after insertion of subclavian central venous catheter http://ctt.ec/Va551+ @ivteam #ivteam” coverup=”Va551″]
Abstract:
A 74-year-old man who had been receiving warfarin for atrial fibrillation, underwent emergency thrombectomy. A central venous catheter (CVC) was inserted via the left subclavian vein, and heparin was administered to prevent preoperative and postoperative thrombotic events. After an uneventful thrombectomy, the patient was transferred to the intensive care unit (ICU). On the second postoperative day, the patient developed syncope and his blood pressure and oxygen saturation decreased. A computed tomography (CT) revealed a huge hematoma under the pectoralis major muscle. The patient was then treated with continuous renal replacement therapy and mechanical ventilation for multiorgan dysfunction syndrome, which developed due to hemorrhagic shock in the ICU. These findings suggest that when a CVC is inserted in patients requiring anticoagulant therapy, the possible risk of excessive bleeding must be carefully considered. Further, choosing a proper insertion site and performing an ultrasound-guided aspiration may be helpful in preventing these complications.
[button link=”http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4252351/pdf/kjae-67-358.pdf” color=”default”]Full Text[/button]
Thank you to our partners for supporting IVTEAM
[slideshow_deploy id=’23788’]